16 related articles for article (PubMed ID: 38438348)
1. Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby G; Wang Y; Wang C; Gao Y; Shelton A; Satterlee AB; Mann BE; Hsiao YC; Liu CW; Liu K; Hingtgen S; Wang J; Liu Z; Miller R; Wu D; Vaziri C; Yang Y
bioRxiv; 2023 Oct; ():. PubMed ID: 37905107
[TBL] [Abstract][Full Text] [Related]
2. Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby G; Wang Y; Wang C; Gao Y; Shelton A; Satterlee AB; Mann BE; Hsiao YC; Liu CW; Liu K; Hingtgen S; Wang J; Liu Z; Miller R; Wu D; Vaziri C; Yang Y
Res Sq; 2023 Oct; ():. PubMed ID: 37886584
[TBL] [Abstract][Full Text] [Related]
3. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
[TBL] [Abstract][Full Text] [Related]
4. MEX3A Impairs DNA Mismatch Repair Signaling and Mediates Acquired Temozolomide Resistance in Glioblastoma.
Gan T; Wang Y; Xie M; Wang Q; Zhao S; Wang P; Shi Q; Qian X; Miao F; Shen Z; Nie E
Cancer Res; 2022 Nov; 82(22):4234-4246. PubMed ID: 36112059
[TBL] [Abstract][Full Text] [Related]
5. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
6. Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby GN; Wang Y; Wang C; Gao Y; Anand JR; Shelton A; Satterlee AB; Mann B; Hsiao YC; Liu CW; Lu K; Hingtgen S; Wang J; Liu Z; Miller CR; Wu D; Vaziri C; Yang Y
Nat Commun; 2024 Mar; 15(1):1957. PubMed ID: 38438348
[TBL] [Abstract][Full Text] [Related]
7. The Role of Mismatch Repair in Glioblastoma Multiforme Treatment Response and Resistance.
Leelatian N; Hong CS; Bindra RS
Neurosurg Clin N Am; 2021 Apr; 32(2):171-180. PubMed ID: 33781500
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]